Lipid Market Report 2025

This Lipid market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The lipid market size has grown strongly in recent years. It will grow from $17.3 billion in 2024 to $18.84 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased consumer awareness of healthy fats, growth in functional foods and nutraceuticals, rise in incidence of cardiovascular diseases, expansion of the food and beverage industry, adoption of personalized nutrition plans.

The lipid market size is expected to see strong growth in the next few years. It will grow to $26.48 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to emphasis on plant-based and omega-3 fatty acids, demand for clean label and non-gmo lipids, research onThe health benefits of lipids, emerging markets and urbanization, regulatory support for health claims, focus on sustainable sourcing and production. Major trends in the forecast period include omega-3 enriched foods and supplements, use of functional lipids in sports nutrition, application of lipids in personalized diets, development of lipid-based drug delivery systems, incorporating plant-based lipids in food products, innovations in lipid extraction and refining.

The growing demand for nutritional supplements is anticipated to propel the growth of the lipid market in the future. Supplementation helps meet the increased nutritional requirements associated with a more active lifestyle or specific medical conditions. Lipid-based nutrient supplements refer to products that derive most of their energy from lipids and include protein, energy, essential fatty acids, and micronutrients. Enhanced access to high-impact health and nutrition services for mothers and children, along with nutrition supplies aimed at promoting children's growth and development, is boosting demand in the lipid market. For instance, in October 2023, a survey of 3,192 adults conducted by the Council for Responsible Nutrition, a U.S.-based trade association for the dietary supplement and functional food industry, revealed that 74% of U.S. adults are using dietary supplements. Additionally, user confidence in the perceived quality of sports nutrition supplements rose by 5 percentage points to 66% compared to 2022, while confidence in the weight management category increased by 4 percentage points to 56% from 2022. Therefore, the demand for nutritional supplements is driving the growth of the lipid market.

The rising prevalence of chronic diseases is expected to drive the growth of the lipid market in the future. The prevalence of chronic diseases refers to the percentage of a population diagnosed with or affected by long-term, non-communicable health conditions such as heart disease, diabetes, or cancer. Lipids play a crucial role in managing chronic diseases due to their various functions in the body, including reducing inflammation, enhancing cardiovascular health, protecting the brain, and supporting the immune system. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), a U.S.-based National Library of Medicine, projected that by 2050, the number of individuals aged 50 years and older with at least one chronic illness will increase by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Thus, the growing prevalence of chronic diseases is driving the demand for the lipid market.

Leading companies in the lipid market are concentrating on developing innovations, such as scalable mixing technology, which reduces risks as developers move from laboratory experiments to clinical applications. Scalable mixing technology in lipid formulation allows for the efficient and uniform blending of lipid-based ingredients across different production scales, ensuring consistency and quality in pharmaceutical formulations. For example, in July 2023, Cytiva, a UK-based biotechnology company, introduced the NanoAssemblr System to support end-to-end clinical and commercial manufacturing of lipid nanoparticle (LNP) medicines. This innovative formulation system employs scalable mixing technology to enable the seamless development of lipid nanoparticle medicines, from clinical trials to large-scale production. It features a single-use fluid path that minimizes the risk of cross-contamination and facilitates efficient batch changeovers, speeding up the time to market. Designed for comprehensive workflows, it enhances reproducibility and scalability, making it ideal for advancing nanoparticle-based therapies in fields such as gene therapy and oncology.

Major players in the lipid market are adopting a strategic partnership approach to provide essential lipid-based solutions across various applications, including pharmaceuticals, food, and cosmetics. This strategic collaboration involves leveraging each other's strengths and resources for mutual benefits. Evonik, a US-based manufacturing company for high-quality lipids, invested $220 million in partnership with the U.S. government in June 2022. The goal is to establish a new lipid production facility for mRNA-based medicines in the United States, strengthening their position as a strategic partner for innovative pharmaceutical businesses worldwide.

In October 2024, KD Pharma Group, a pharmaceutical manufacturing company based in Switzerland, acquired the Marine Lipids business from DSM-Firmenich for an undisclosed amount. This acquisition is intended to broaden KD Pharma Group's capabilities in the marine lipids market. By acquiring DSM-Firmenich’s Marine Lipids business, KD Pharma can enhance its portfolio of omega-3 products and solidify its position in the nutraceutical and pharmaceutical sectors. DSM-Firmenich is a nutrition, health, and sustainable living company located in the Netherlands.

Major companies operating in the lipid market include Aveda Corporation, Burt’s Bees Inc., The Estée Lauder Companies Inc., The Hain Celestial Group Inc., Amway Corporation, Bare Escentuals Beauty Inc., Arbonne International LLC, The Body Shop International PLC, Yves Rocher SA, L'Oréal S.A., Beiersdorf AG, Neutrogena Corporation, L'Occitane International S.A., Thesis Beauty, Eminence Organic Skincare Inc., Natura Cosméticos S.A, Weleda AG, Hindustan Unilever Limited (HUL), Fancl Corporation, DHC Corporation, Shanghai Pechoin Daily Chemical Co Ltd., JALA Group Co. Ltd., Shea Terra Organics LLC, Archer Daniels Midland Company, BASF SE, Koninklijke DSM N.V., Reckitt Benckiser Group PLC, Kerry Group PLC, Clover Corporation Limited, Croda International PLC, FMC Corporation, Cargill Corporation, Nordic Naturals Inc., Solutex Corp., Omega Protein Corporation, Merck Millipore Limited, Stepan Company, NOF Corporation.

Asia-Pacific was the largest region in the lipid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the lipid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Lipids serve various purposes, including providing insulation, aiding in digestion, and enhancing bioavailability. These large chemical molecules, categorized as derivatives of fatty acids or closely related substances, are typically insoluble in water but highly soluble in organic solvents and alcohols. Their applications extend to the cosmetic and food industries, as well as nanotechnology.

The primary types of lipids include omega-3, omega-6, and medium-chain triglycerides (MCT). Omega-3 lipids, found in fish oil, particularly in cold-water fish like salmon, play a crucial role in reducing cholesterol and LDL levels in the bloodstream. Lipids come in different forms such as phospholipids, glycolipids, and cholesterol, which find use in diverse applications like food and beverages, pharmaceuticals, nutrition and supplements, and more.

The lipid market research report is one of a series of new reports that provides lipid market statistics, including lipid industry global market size, regional shares, competitors with lipid market share, detailed lipid market segments, market trends, and opportunities, and any further data you may need to thrive in the lipids industry. This lipid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lipid market consists of sales of fats, oils, hormones, and waxes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.